Abstract
SummaryRabbit anti-mouse thymocyte serum significantly modified the course of mouse LCM virus infection. Clinical and histologic signs of infection were absent so long as therapy was regularly maintained, and the severity of the host response to the virus was reduced following discontinuation of prolonged therapy. Treatment in the early period of incubation was more protective than at later times.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
